Key Insights

Highlights

Treatment Research

7 treatments under study, led by Ssrs In 1 Fraction

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04218617Phase 2Recruiting

Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases

Showing all 1 trials

Research Network

Common Treatments

  • Ssrs In 1 Fraction1
  • Ssrs In 2 Fraction1
  • Brief Pain Inventory Bpi1
  • Planning Mri1
  • Qol Assessment1

Active Sponsors

  • Case Comprehensive Cancer Center1

Top Investigators

  • Samuel Chao, MD1

    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center

Related Conditions

  • Spine Metastases1

Activity Timeline